ロード中...
Long-term effect of thymectomy in patients with non-thymomatous myasthenia gravis treated with prednisone: 2-year extension of the MGTX randomised trial
BACKGROUND: The MGTX trial demonstrated that thymectomy combined with prednisone was superior to prednisone alone in improving clinical status measured by the Quantitative MG (QMG) score in patients with non-thymomatous myasthenia gravis at 3 years. We investigated the long-term effects of thymectom...
保存先:
| 出版年: | Lancet Neurol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6774753/ https://ncbi.nlm.nih.gov/pubmed/30692052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(18)30392-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|